2025 annual financial data
ProQR Therapeutics 2025 Net margin
Direct answer
Net margin was -265.21%.
Operating income was -42.15M EUR and net income was -40.52M EUR.
Operating cash flow was -50.71M EUR.
Get free ProQR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 15.28M EUR
- Operating income
- -42.15M EUR
- Net income
- -40.52M EUR
- Operating cash flow
- -50.71M EUR